Lipidomics Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Lipidomics Market: By Type (Blood Sample, Tissue Sample, and Others), By lipid source (Human Source, Animal Source, and Plant Source), By Application (Drug Discovery, Biomarker Discovery, Personalized Medicine, Diagnosis and Treatment, and Others), and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

Lipidomics Market size is anticipated to be valued at USD 50.0 million in 2021 and is expanded to grow at a significant CAGR of 8.0% over 2022-2028. Lipidomics is a growing field of biomedical study that encompasses lipidome analysis. It’s a complete and quantitative description of a collection of lipid species found in an organism. The worldwide lipidomics market is predicted to benefit from a wide range of lipidomics applications, as well as an increase in the prevalence of target diseases such as malignancies and the breadth of clinical trials and toxicological investigations. During the forecast period, the Lipidomics market is expected to rise rapidly. Novel technology approvals, as well as other organic growth tactics such as patents and events, are being prioritized by a lot of companies. Acquisitions, as well as collaborations and partnerships, were considered inorganic growth tactics in the market. These activities have paved the way for the expansion of business and the customer base of market players. The rise in need for precise illness diagnosis, demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. Growth is attributed to meeting the requirements of aging populations and infants, and the prevalence of chronic diseases and changing food habits contribute to the intake of supplements and energy-providing food are boosting the global lipidomics market. In the forecast period of 2021-2028, rising raw material and technology costs are expected to pose a challenge to the lipid market. Over the anticipated period, the market is expected to rise due to an increase in the demand for precise illness diagnosis, growth in demand for personalized treatment, technological advancements in the field of lipidomics, and large investments from the public and commercial sectors in R&D activities.

Key Developments:

In July 2020, Croda International Plc (‘Croda’) confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.

In March 2020, Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology.

 

Lipidomics Market

MARKET SUMMARY
-
8.0%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.0%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Lipidomics Market

  • The report on lipidomics market gives historical, current, and future market sizes of sample type, service type, lipid source, application, end user and geographic regions.
  • Lipidomics Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Zora Biosciences Oy (Finland)
  • OWL Metabolomics (Spain)
  • ProSciento (U.S.)
  • Avanti Lipids Polar, Inc. (U.S.)
  • VCU Massey Cancer Center (U.S.)
  • Lipotype GmbH (Germany)
  • Metabolon, Inc. (U.S.)
  • Waters Corporation (U.S.)
  • Lipotype GmbH (Germany)
Lipidomics Market Dynamics

The rise in the need for accurate illness diagnosis, demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. Increasing industrialization and growing health consciousness and awareness about the health benefits of lipids. However, the lipidomics market’s growth is hampered by strict regulatory rules, a lack of modern instruments, a lack of technology acceptance, and a scarcity of experienced researchers


North-America Got Significant Share

North America dominates the lipidomics market during the forecast period of 2021-2028 because of the growth of women nutrition markets, favorable environment, consumption of fats, local availability of fats and oils, high production rate, low cost, high application in food and beverage industry, innovative technologies and new application in the region. Furthermore, an increase in the population and birth rate, and an increase in the prevalence of diabetes and other targeted diseases, and an increase in R&D activities in China, Japan, and India.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Key Developments

Lipidomics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The lipidomics market is projected to expand at a CAGR of 8.0% during the forecast period

Lipotype GmbH, Metabolon, Inc., Waters Corporation, Creative Proteomics, Thermo Fisher Scientific, MetaSysX

North America is the fastest-growing region for lipidomics market


Report

Company Profile

  • Zora Biosciences OY
  • Owl Metabolomics
  • Avanti Lipids Polar, Inc.
  • The Metabolomics Innovation Centre
  • Lipotype GmbH
  • Metabolon, Inc.
  • Waters Corporation
  • Creative Proteomics
  • Thermo Fisher Scientific
  • MetaSysX

Description

Lipidomics Market size is anticipated to be valued at USD 50.0 million in 2021 and is expanded to grow at a significant CAGR of 8.0% over 2022-2028. Lipidomics is a growing field of biomedical study that encompasses lipidome analysis. It’s a complete and quantitative description of a collection of lipid species found in an organism. The worldwide lipidomics market is predicted to benefit from a wide range of lipidomics applications, as well as an increase in the prevalence of target diseases such as malignancies and the breadth of clinical trials and toxicological investigations. During the forecast period, the Lipidomics market is expected to rise rapidly. Novel technology approvals, as well as other organic growth tactics such as patents and events, are being prioritized by a lot of companies. Acquisitions, as well as collaborations and partnerships, were considered inorganic growth tactics in the market. These activities have paved the way for the expansion of business and the customer base of market players. The rise in need for precise illness diagnosis, demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. Growth is attributed to meeting the requirements of aging populations and infants, and the prevalence of chronic diseases and changing food habits contribute to the intake of supplements and energy-providing food are boosting the global lipidomics market. In the forecast period of 2021-2028, rising raw material and technology costs are expected to pose a challenge to the lipid market. Over the anticipated period, the market is expected to rise due to an increase in the demand for precise illness diagnosis, growth in demand for personalized treatment, technological advancements in the field of lipidomics, and large investments from the public and commercial sectors in R&D activities.

Key Developments:

In July 2020, Croda International Plc (‘Croda’) confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.

In March 2020, Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX